EXTRAMEDIASTINAL LESION IN PATIENTS WITH PRIMARY MEDIASTINAL B-CELL LYMPHOMA

Background. Extramediastinal and bone marrow involvement in PMBCL patients in the onset of the disease is an exception to the rules and complete information, except for the word “rare”, in Russian and international literature is not available.Objective: to characterize PMBCL patients with extramedia...

Full description

Bibliographic Details
Main Authors: Ya. K. Mangasarova, A. U. Magomedova, A. M. Kovrigina, I. E. Kostina, E. S. Nesterova, L. G. Gorenkova, A. E. Misyurina, O. V. Margolin, S. K. Kravchenko
Format: Article
Language:Russian
Published: ABV-press 2018-05-01
Series:Онкогематология
Subjects:
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/273
_version_ 1797855580807757824
author Ya. K. Mangasarova
A. U. Magomedova
A. M. Kovrigina
I. E. Kostina
E. S. Nesterova
L. G. Gorenkova
A. E. Misyurina
O. V. Margolin
S. K. Kravchenko
author_facet Ya. K. Mangasarova
A. U. Magomedova
A. M. Kovrigina
I. E. Kostina
E. S. Nesterova
L. G. Gorenkova
A. E. Misyurina
O. V. Margolin
S. K. Kravchenko
author_sort Ya. K. Mangasarova
collection DOAJ
description Background. Extramediastinal and bone marrow involvement in PMBCL patients in the onset of the disease is an exception to the rules and complete information, except for the word “rare”, in Russian and international literature is not available.Objective: to characterize PMBCL patients with extramediastinal involvement.Materials and methods. From 2007 to 2017 diagnosis of PMBCL was established in 157 patients according to WHO criteria with extramediastinal involvement in 16 (10.2 %) patients, 3 of them were at different stages of pregnancy. The median age was 27 years (23–69). Patients received different therapy protocols: m-NHL-BFM-90, R-DA-EPOCH и VACOP-B.Results. One extramediastinal lesion was verified in 11/16 (68.7 %) patients, multiple – in 5/11 (31.3 %). The most common localizations were: pancreas – 6 (37.5 %), kidneys – 5 (31.2 %), ovaries – 3 (18.7 %), liver – 3 (18.7 %), bone marrow – 3 (18.7 %) and breast – 2 (12 %) cases. Involvement of stomach, bones, soft tissues, spleen, pelvis, adrenal gland was revealed in one case each. In 15/16 cases, extramediastinal lesions were combined with antero-superior mediastinum involvement and only in 1 cases an isolated lesion of the soft thorax tissues without involvement of mediastinal structures was revealed. Five-year overall survival in the group of patients with classical PMBCL who received R-DA-EPOCH, m-NHL-BFM-90 and cohort of patients with extramediastinal lesions was comparable and was 93 %. As a result of the analysis, in 10.2 % (16/157) of cases extramediastinal involvement was revealed. In all cases, there is involvement of organs and tissues, but not the lymph nodes. In 18.7 % (3/16) of cases there was bone marrow involvement, confirmed by molecular and histological studies.Conclusion. Involvement of the antero-superior mediastinum and the presence of extramediastinal lesion, bone marrow involvement is not excluding criterion for PMBCL, but requires differential diagnosis with DBCL, including standard and molecular methods. Is isolated extramediastinal involvement in PMBCL a poor prognostic factor, is uncertain because of the small number of observations.
first_indexed 2024-04-09T20:24:55Z
format Article
id doaj.art-fede468a12584f2bba3f0d091856bd4c
institution Directory Open Access Journal
issn 1818-8346
2413-4023
language Russian
last_indexed 2024-04-09T20:24:55Z
publishDate 2018-05-01
publisher ABV-press
record_format Article
series Онкогематология
spelling doaj.art-fede468a12584f2bba3f0d091856bd4c2023-03-30T20:15:12ZrusABV-pressОнкогематология1818-83462413-40232018-05-01131212810.17650/1818-8346-2018-13-1-21-28257EXTRAMEDIASTINAL LESION IN PATIENTS WITH PRIMARY MEDIASTINAL B-CELL LYMPHOMAYa. K. Mangasarova0A. U. Magomedova1A. M. Kovrigina2I. E. Kostina3E. S. Nesterova4L. G. Gorenkova5A. E. Misyurina6O. V. Margolin7S. K. Kravchenko8National Research Center for HematologyNational Research Center for HematologyNational Research Center for HematologyNational Research Center for HematologyNational Research Center for HematologyNational Research Center for HematologyNational Research Center for HematologyNational Research Center for HematologyNational Research Center for HematologyBackground. Extramediastinal and bone marrow involvement in PMBCL patients in the onset of the disease is an exception to the rules and complete information, except for the word “rare”, in Russian and international literature is not available.Objective: to characterize PMBCL patients with extramediastinal involvement.Materials and methods. From 2007 to 2017 diagnosis of PMBCL was established in 157 patients according to WHO criteria with extramediastinal involvement in 16 (10.2 %) patients, 3 of them were at different stages of pregnancy. The median age was 27 years (23–69). Patients received different therapy protocols: m-NHL-BFM-90, R-DA-EPOCH и VACOP-B.Results. One extramediastinal lesion was verified in 11/16 (68.7 %) patients, multiple – in 5/11 (31.3 %). The most common localizations were: pancreas – 6 (37.5 %), kidneys – 5 (31.2 %), ovaries – 3 (18.7 %), liver – 3 (18.7 %), bone marrow – 3 (18.7 %) and breast – 2 (12 %) cases. Involvement of stomach, bones, soft tissues, spleen, pelvis, adrenal gland was revealed in one case each. In 15/16 cases, extramediastinal lesions were combined with antero-superior mediastinum involvement and only in 1 cases an isolated lesion of the soft thorax tissues without involvement of mediastinal structures was revealed. Five-year overall survival in the group of patients with classical PMBCL who received R-DA-EPOCH, m-NHL-BFM-90 and cohort of patients with extramediastinal lesions was comparable and was 93 %. As a result of the analysis, in 10.2 % (16/157) of cases extramediastinal involvement was revealed. In all cases, there is involvement of organs and tissues, but not the lymph nodes. In 18.7 % (3/16) of cases there was bone marrow involvement, confirmed by molecular and histological studies.Conclusion. Involvement of the antero-superior mediastinum and the presence of extramediastinal lesion, bone marrow involvement is not excluding criterion for PMBCL, but requires differential diagnosis with DBCL, including standard and molecular methods. Is isolated extramediastinal involvement in PMBCL a poor prognostic factor, is uncertain because of the small number of observations.https://oncohematology.abvpress.ru/ongm/article/view/273primary mediastinal (thymic) b-cell large-cell lymphomadistant extramediastinal lesionbone marrow involvement
spellingShingle Ya. K. Mangasarova
A. U. Magomedova
A. M. Kovrigina
I. E. Kostina
E. S. Nesterova
L. G. Gorenkova
A. E. Misyurina
O. V. Margolin
S. K. Kravchenko
EXTRAMEDIASTINAL LESION IN PATIENTS WITH PRIMARY MEDIASTINAL B-CELL LYMPHOMA
Онкогематология
primary mediastinal (thymic) b-cell large-cell lymphoma
distant extramediastinal lesion
bone marrow involvement
title EXTRAMEDIASTINAL LESION IN PATIENTS WITH PRIMARY MEDIASTINAL B-CELL LYMPHOMA
title_full EXTRAMEDIASTINAL LESION IN PATIENTS WITH PRIMARY MEDIASTINAL B-CELL LYMPHOMA
title_fullStr EXTRAMEDIASTINAL LESION IN PATIENTS WITH PRIMARY MEDIASTINAL B-CELL LYMPHOMA
title_full_unstemmed EXTRAMEDIASTINAL LESION IN PATIENTS WITH PRIMARY MEDIASTINAL B-CELL LYMPHOMA
title_short EXTRAMEDIASTINAL LESION IN PATIENTS WITH PRIMARY MEDIASTINAL B-CELL LYMPHOMA
title_sort extramediastinal lesion in patients with primary mediastinal b cell lymphoma
topic primary mediastinal (thymic) b-cell large-cell lymphoma
distant extramediastinal lesion
bone marrow involvement
url https://oncohematology.abvpress.ru/ongm/article/view/273
work_keys_str_mv AT yakmangasarova extramediastinallesioninpatientswithprimarymediastinalbcelllymphoma
AT aumagomedova extramediastinallesioninpatientswithprimarymediastinalbcelllymphoma
AT amkovrigina extramediastinallesioninpatientswithprimarymediastinalbcelllymphoma
AT iekostina extramediastinallesioninpatientswithprimarymediastinalbcelllymphoma
AT esnesterova extramediastinallesioninpatientswithprimarymediastinalbcelllymphoma
AT lggorenkova extramediastinallesioninpatientswithprimarymediastinalbcelllymphoma
AT aemisyurina extramediastinallesioninpatientswithprimarymediastinalbcelllymphoma
AT ovmargolin extramediastinallesioninpatientswithprimarymediastinalbcelllymphoma
AT skkravchenko extramediastinallesioninpatientswithprimarymediastinalbcelllymphoma